(Q40561379)

21 September 2017

title

Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis (English)

1 reference

21 September 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/S8756-3282(03)00223-0

11 March 2024

author name string

A. Evdokiou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499355

11 March 2024

A. Labrinidis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499355

11 March 2024

S. Bouralexis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499355

11 March 2024

S. Hay

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499355

11 March 2024

D. M. Findlay

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499355

11 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14499355

11 March 2024

publication date

1 August 2003

1 reference

full work available at URL

21 September 2017

https://api.elsevier.com/content/article/PII:S8756328203002230?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S8756-3282(03)00223-0

https://api.elsevier.com/content/article/PII:S8756328203002230?httpAccept=text/plain

11 March 2024

1 reference

https://api.crossref.org/works/10.1016/S8756-3282(03)00223-0

11 March 2024

1 reference

21 September 2017

volume

33

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

216-228

1 reference

Osteosarcomas and other cancers of bone

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Bone mass homeostasis and bisphosphonate action

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: the effect of a bisphosphonate.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Bisphosphonates act on rat bone resorption through the mediation of osteoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Protein prenylation: molecular mechanisms and functional consequences

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Bisphosphonates induce breast cancer cell death in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Bisphosphonates induce apoptosis in human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Additive antitumor activities of taxoids in combination with the bisphosphonate ibandronate against invasion and adhesion of human breast carcinoma cells to bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Zoledronic acid in cancer patients with bone metastases: results of Phase I and II trials

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Bisphosphonates act directly on the osteoclast to induce caspase cleavage of mst1 kinase during apoptosis. A link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Ultrastructural and cytochemical studies on cell death of osteoclasts induced by bisphosphonate treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

1 reference

7 January 2021

Triggering caspase-independent cell death to combat cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Reduction in new metastases in breast cancer with adjuvant clodronate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

The bisphosphonate pamidronate is a potent inhibitor of human osteosarcoma cell growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900223-0

7 January 2021

The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway

16

1 reference

https://api.crossref.org/works/10.1016/S8756-3282(03)00223-0

Bisphosphonate treatment inhibits the growth of prostate cancer cells

11 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/S8756-3282(03)00223-0

A phase I dose-ranging trial of monthly infusions of zoledronic acid for the treatment of osteolytic bone metastases

11 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/S8756-3282(03)00223-0

11 March 2024

Identifiers

1 reference

21 September 2017

1 reference